International Clinical Trial: ALDH1B1 participates in the research on the pathogenesis of inflammatory demyelinating diseases in the central nervous system by regulating Th17 differentiation through mitochondrial metabolic reprogramming

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132401) titled 'ALDH1B1 participates in the research on the pathogenesis of inflammatory demyelinating diseases in the central nervous system by regulating Th17 differentiation through mitochondrial metabolic reprogramming' on Sept. 14.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University

Condition: inflammatory demyelinating diseases

Intervention: healthy Control group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-15

Target Sample Size: healthy Control group:50;inflammatory demyelinating diseas...